Gainers
- IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.
- TaskUs, Inc. (NASDAQ: TASK) shares climbed 37.1% to $21.99 after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
- Oportun Financial Corporation (NASDAQ: OPRT) gained 36.1% to $5.65 after the company announced upbeat Q3 results.
- GrowGeneration Corp. (NASDAQ: GRWG) shares climbed 29.9% to $4.30 after the company reported better-than-expected Q3 sales.
- SkyWater Technology, Inc. (NASDAQ: SKYT) gained 25.8% to $10.87 after the company reported better-than-expected Q3 EPS and sales results.
- Exela Technologies, Inc. (NASDAQ: XELA) rose 25% to $0.2161.
- Allakos Inc. (NASDAQ: ALLK) jumped 25% to $7.65 following a narrower-than-expected Q3 loss.
- Triumph Group, Inc. (NYSE: TGI) surged 23.7% to $11.77 after the company reported upbeat quarterly sales and raised FY23 earnings guidance.
- Unique Fabricating, Inc. (NYSE: UFAB) surged 23.4% to $0.6480.
- eHealth, Inc. (NASDAQ: EHTH) gained 22.6% to $3.90 following strong Q3 results.
- Rover Group, Inc. (NASDAQ: ROVR) jumped 22.3% to $5.04 after the company posted a narrower quarterly loss and issued strong sales forecast.
- NeoGenomics, Inc. (NASDAQ: NEO) gained 21.5% to $8.63 following better-than-expected Q3 results.
- Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) jumped 19.3% to $3.9950 following Q3 results.
- Avalon GloboCare Corp. (NASDAQ: AVCO) rose 19.2% to $0.6695. Avalon Globocare reported a deal to buy 60% interest in Laboratory Services MSO for $31 million in cash and preferred shares.
- AAON, Inc. (NASDAQ: AAON) gained 19.2% to $78.13 following upbeat Q3 resulst.
- Hims & Hers Health, Inc. (NYSE: HIMS) rose 19% to $5.50 after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
- Loyalty Ventures Inc. (NASDAQ: LYLT) jumped 18.6% to $1.7200 following Q3 results.
- Bit Brother Limited (NASDAQ: BTB) gained 18.1% to $0.1520.
- SolarEdge Technologies, Inc. (NASDAQ: SEDG) rose 17.7% to $248.77 after the company reported better-than-expected Q3 sales results and issued Q4 sales guidance with a midpoint above analyst estimates..
- First Advantage Corporation (NASDAQ: FA) gained 17% to $12.14 following Q3 results.
- Ocuphire Pharma, Inc. (NASDAQ: OCUP) shares rose 16.5% to $2.4350. Ocuphire Pharma entered into a global license agreement for development and commercialization of Nyxol Eye Drops for reversal of mydriasis, presbyopia and night vision disturbances.
- CTI BioPharma Corp. (NASDAQ: CTIC) rose 16.4% to $5.78 after the company reported better-than-expected Q3 EPS and sales results.
- Five9, Inc. (NASDAQ: FIVN) gained 16.4% to $54.71 following Q3 results.
- Veritiv Corporation (NYSE: VRTV) gained 16.1% to $126.27 after the company posted upbeat Q3 results and raised FY22 EPS guidance.
- Reata Pharmaceuticals, Inc. (NASDAQ: RETA) jumped 16% to $40.51 following Q3 results.
- Selina Hospitality PLC (NASDAQ: SLNA) gained 15.8% to $4.4966.
- Tenaya Therapeutics, Inc. (NASDAQ: TNYA) shares rose 15% to $2.2083. Canaccord Genuity initiated coverage on Tenaya Therapeutics with a Buy rating and announced a price target of $21.
- Virgin Orbit Holdings, Inc. (NASDAQ: VORB) gained 14% to $3.3313 after the company reported Q3 financial results.
- International Game Technology PLC (NYSE: IGT) jumped 13.8% to $22.72. International Game Technology reported third-quarter FY22 revenue growth of 14% year-on-year to $1.06 billion (at constant currency), beating the consensus of $1.01 billion.
- Lordstown Motors Corp. (NASDAQ: RIDE) rose 12.7% to $2.0840 after the company announced Foxconn will invest up to $170 million in the company.
- uCloudlink Group Inc. (NASDAQ: UCL) rose 11% to $1.0227 after gaining over 4% on Monday.
- SunPower Corporation (NASDAQ: SPWR) gained 10.4% to $18.62 after the company reported better-than-expected Q3 EPS and sales results.
- The Hain Celestial Group, Inc. (NASDAQ: HAIN) rose 10.3% to $20.99 following upbeat quarterly earnings.
- Planet Fitness, Inc. (NYSE: PLNT) gained 9.5% to $67.60 after the company reported better-than-expected Q3 adjusted EPS and sales results.
- LivePerson, Inc. (NASDAQ: LPSN) rose 8.9% to $11.02 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.
- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) gained 7.7% to $17.95 after the company reported better-than-expected Q3 EPS and sales results and issued Q4 guidance.
- 2U, Inc. (NASDAQ: TWOU) rose 3.6% to $6.58 after reporting strong Q3 sales. Piper Sandler upgraded 2U from Underweight to Neutral and lowered the price target from $8 to $7.
- NanoString Technologies, Inc. (NASDAQ: NSTG) shares dipped 47.5% to $4.84 after the company reported worse-than-expected Q3 results.
- Fast Radius, Inc. (NASDAQ: FSRD) dropped 47% to $0.1533 after the company filed voluntary petitions for relief under Chapter 11.
- Bioventus Inc(NASDAQ: BVS) fell 45.1% to $3.8750 after the company reported downbeat Q3 results and lowered FY22 guidance.
- R1 RCM Inc. (NASDAQ: RCM) dropped 44.2% to $8.23 after the company reported worse-than-expected Q3 EPS and sales results and cut FY22 revenue guidance below estimates.
- Unisys Corporation (NYSE: UIS) fell 41.2% to $5.27 following downbeat quarterly sales.
- NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) dipped 40.5% to $1.2850 after dipping 17% on Monday. NeuroBo Pharmaceuticals recently announced pricing of a $30 million underwritten public offering and concurrent private placement.
- Athersys, Inc. (NASDAQ: ATHX) shares fell 38% to $1.40 after the company reported a proposed public offering.
- Party City Holdco Inc. (NYSE: PRTY) dipped 38% to $0.9499 after the company reported worse-than-expected Q3 results.
- Arrival (NASDAQ: ARVL) dropped 36.7% to $0.3755 after the company announced a Q3 business update.
- Digital Brands Group, Inc. (NASDAQ: DBGI) declined 28% to $4.7650.
- The Pennant Group, Inc. (NASDAQ: PNTG) fell 27.2% to $9.87 following downbeat quarterly earnings.
- Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) dropped 26% to $0.9349.
- WM Technology, Inc. (NASDAQ: MAPS) dipped 25.1% to $1.4450 after the company reported worse-than-expected Q3 sales results.
- Clarus Corporation (NASDAQ: CLAR) dropped 24.9% to $8.27 after the company reported worse-than-expected Q3 results and issued FY22 guidance below estimates.
- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) fell 24.5% to $1.23 following weak quarterly results.
- ATI Physical Therapy, Inc. (NASDAQ: ATIP) declined 24.2% to $0.8495 after the company said there is doubt about its ability to continue as a going concern within 12 months following the issuance date of its financial statements for the period ended Sept. 30
- Tripadvisor, Inc. (NASDAQ: TRIP) shares fell 21.8% to $18.61 after the company reported worse-than-expected Q3 EPS results.
- Versus Systems Inc. (NASDAQ: VS) dropped 20.6% to $0.1801 after the company announced a 1-for-15 reverse stock split to aid compliance with Nasdaq listing requirements.
- Lyft (NASDAQ:LYFT), Inc. (NASDAQ: LYFT) shares fell 20.2% to $11.29 after the company reported worse-than-expected Q3 sales results and issued Q4 sales guidance below analyst estimates. Evercore ISI Group downgraded Lyft from Outperform to In-Line and lowered the price target from $41 to $18.
- Cognition Therapeutics, Inc. (NASDAQ: CGTX) dipped 19.8% to $1.3699 after the company filed for an offering of up to 5.6 million shares of common stock.
- Kaleyra, Inc. (NYSE: KLR) dropped 19.5% to $0.6676 following weak quarterly sales.
- Akoya Biosciences, Inc. (NASDAQ: AKYA) fell 18.3% to $10.63 as the company posted a wider-than-expected quarterly loss.
- MeridianLink, Inc. (NYSE: MLNK) fell 17.9% to $13.24 after reporting a loss for the tird quarter.
- Ocular Therapeutix, Inc. (NASDAQ: OCUL) dipped 17.8% to $2.9199 following Q3 loss.
- Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) dropped 17.8% to $4.61 after the company reported Q3 financial results.
- Broadmark Realty Capital Inc. (NYSE: BRMK) fell 16.4% to $4.7050 after reporting downbeat quarterly results. The company also named Jeffrey Pyatt as Interim CEO and Jonathan Hermes as Chief Financial Officer.
- MicroStrategy Incorporated (NASDAQ: MSTR) dropped 14.5% to $228.00 in sympathy with the price of Bitcoin and Ethereum.
- Silvergate Capital Corporation (NYSE: SI) declined 14.4% to $43.59. Silvergate announced changes to its executive team.
- Perrigo Company plc (NYSE: PRGO) dropped 14.1% to $33.75 as the company lowered FY22 profit forecast.
- Lumentum Holdings Inc. (NASDAQ: LITE) fell 13.8% to $60.62 after the company issued Q3 EPS and sales guidance below estimates.
- Agile Therapeutics, Inc. (NASDAQ: AGRX) fell 13.8% to $0.2749 after the company reported a loss for its third quarter.
- ChromaDex Corporation (NASDAQ: CDXC) dropped 13.2% to $1.8753.
- Alto Ingredients, Inc. (NASDAQ: ALTO) fell 12.9% to $3.6150 after the company reported Q3 earnings. The company said results were impacted by logistical constraints, increased transportation costs and low commodity margins.
- Take-Two (NASDAQ:TTWO) Interactive Software, Inc. (NASDAQ: TTWO) fell 12.2% to $95.13 after the company reported worse-than-expected Q2 results and issued weak FY23 guidance.
- SI-BONE, Inc. (NASDAQ: SIBN) dipped 12.1% to $14.73 following Q3 results.
- FibroGen, Inc. (NASDAQ: FGEN) fell 11.8% to $14.24 following weak quarterly results.
- Ramaco Resources, Inc. (NASDAQ: METC) shares fell 11.2% to $11.07 after the company reported worse-than-expected Q3 results.
- Coinbase (NASDAQ:COIN) Global, Inc. (NASDAQ: COIN) dropped 10.2% to $51.17. Crypto-related stocks dropped sharply amid marked, ongoing volatility in the broader crypto space amid reports of a possible bankruptcy of popular cryptocurrency exchange FTX.
- MicroCloud Hologram Inc. (NASDAQ: HOLO) shares fell 8.6% to $2.14 after dropping over 7% on Monday.
- DigitalOcean Holdings, Inc. (NASDAQ: DOCN) fell 6.6% to $27.46 after the company issued a weak forecast for the fourth quarter.